Insights Into PROM1 -Macular Disease Using Multimodal Imaging
Investigative Opthalmology & Visual Science · 2023
DOI: 10.1167/iovs.64.4.27 ↗Kurz gefasst
Fachartikel in der Zeitschrift Investigative Opthalmology & Visual Science, 2023. Verfasst von Maarjaliis Paavo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Departments of Ophthalmology, Columbia University Medical Center, New York, New York, United States. Hauptthemen laut MEDLINE: Macular Degeneration, Retinal Dystrophies. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS, NIH HHS.
Abstract (Originalsprache)
Purpose
To describe the features of genetically confirmed PROM1-macular dystrophy in multimodal images.
Methods
Thirty-six (36) eyes of 18 patients (5-66 years; mean age, 42.4 years) were prospectively studied by clinical examination and multimodal imaging. Short-wavelength autofluorescence (SW-AF) and quantitative fundus autofluorescence (qAF) images were acquired with a scanning laser ophthalmoscope (HRA+OCT, Heidelberg Engineering) modified by insertion of an internal autofluorescent reference. Further clinical testing included near-infrared autofluorescence (NIR-AF; HRA2, Heidelberg Engineering) with semiquantitative analysis, spectral domain-optical coherence tomography (HRA+OCT) and full-field electroretinography. All patients were genetically confirmed by exome sequencing.
Results
All 18 patients presented with varying degrees of maculopathy. One family with individuals affected across two generations exhibited granular fleck-like deposits across the posterior pole. Areas of granular deposition in SW-AF and NIR-AF corresponded to intermittent loss of the ellipsoid zone, whereas discrete regions of hypoautofluorescence corresponded with a loss of outer retinal layers in spectral-domain optical coherence tomography scans. For 18 of the 20 eyes, qAF levels within the macula were within the 95% confidence intervals of healthy age-matched individuals; nor was the mean NIR-AF signal increased relative to healthy eyes.
Conclusions
Although PROM1-macular dystrophy (Stargardt disease 4) can exhibit phenotypic overlap with recessive Stargardt disease, significantly increased SW-AF levels were not detected. As such, elevated bisretinoid lipofuscin may not be a feature of the pathophysiology of PROM1 disease. The qAF approach could serve as a method of early differential diagnosis and may help to identify appropriate disease targets as therapeutics become available to treat inherited retinal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Departments of Ophthalmology, Columbia University Medical Center, New York, New York, United States.
- Helsinki University Eye Hospital, Helsinki, Finland.
- Pathology and Cell Biology, Columbia University Medical Center, New York, New York, United States.
Förderung
- NEI NIH HHS
- NIH HHS
Zitieren
APA
Paavo, M., Lee, W., Parmann, R., Lima de Carvalho, J. R., Zernant, J., Tsang, S. H., Allikmets, R., & Sparrow, J. R. (2023). Insights Into PROM1 -Macular Disease Using Multimodal Imaging. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.4.27
Vancouver
Paavo M, Lee W, Parmann R, Lima de Carvalho JR, Zernant J, Tsang SH, et al. Insights Into PROM1 -Macular Disease Using Multimodal Imaging. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.4.27
BibTeX
@article{Paavo2023,
author = {Paavo, Maarjaliis and Lee, Winston and Parmann, Rait and Lima de Carvalho, Jose Ronaldo and Zernant, Jana and Tsang, Stephen H and Allikmets, Rando and Sparrow, Janet R},
title = {Insights Into PROM1 -Macular Disease Using Multimodal Imaging},
journal = {Investigative Opthalmology & Visual Science},
year = {2023},
doi = {10.1167/iovs.64.4.27}
}
EUVIMED